L16: Lipoproteins Flashcards

1
Q

LO1/LO2: Describe the major differences in the composition, physical properties, and apoprotein content of chylomicrons and VLDLs

A

chylomicrons (transport triglycerides, intestine): largest, lowest density, primarily lipids (mostly TAGs), ApoB-48, ApoC11, Apo E

VLDLs (transport triglycerides, liver): second largest, second lowest density, primarily lipids (majority TAGs, followed by PL, CE, C), ApoB-100, ApoC11, ApoE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

LO1/LO2: Describe the major differences in the composition, physical properties, and apoprotein content of LDLs and HDLs

A

LDLs (transport cholesterol, plasma IDL): second smallest, more dense, 79% lipids/21% proteins, (half CE, remaining PL, TAG, CE), ApoB-100

HDLs (reservoir of apoproteins/reverse cholesterol transport, liver+intestine): smallest, highest density, equal parts protein+lipid (mostly CE and PL with some TAGs and C), Apo A, Apo C, Apo E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

LO2: List the functions of the major classes of lipoproteins and where each is formed

A

CHYLOMICRONS-transport dietary triglycerides to peripheral tissues; formed in intestine

VLDLs- transport triglycerides to peripheral tissues; formed in liver

IDLs- transport triglycerides/precursors to LDLs; formed in plasma VLDL

LDLs- transport cholesterol to peripheral tissues; formed in plasma IDL

HDLs- reservoir of apoproteins/reverse cholesterol transport; formed in liver+intestine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

LO3: Name two apoproteins that serve as ligands for cell surface receptors and two apoproteins that are activators of enzymes involved in lipoprotein metabolism

A

LIGANDS FOR RECEPTORS
Apo E: recognition of remnant receptors to initiate receptor-mediated endocytosis in liver
Apo B-100: recognition of LDL receptors to initiate receptor-mediated endocytosis

ACTIVATORS OF ENZYMES
Apo A-1: stimulates LCAT to esterify cholesterol for mobilization for reverse cholesterol transport

Apo CII: triggers LPL to hydrolyze triglycerides from chylomicrons into blood stream

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

LO4: Describe the function, location, and regulation of LPL

A

FUNCTION
-hydrolyze the triglycerides in circulating chylomicrons to free fatty acids and glycerol

LOCATION
-bound by heparin sulfate in the luminal wall of capillaries in most tissues (enriched in the capillary bed of adipose, muscle, and cardiac tissue)

REGULATION

  • activated by ApoCII
  • synthesis in adipocytes stimulated by insulin
  • synthesis in other tissues not affected by insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

LO5: Compare/contrast the properties of LPL and hepatic lipase

A

HEPATIC LIPASE
FUNCTION
-metabolizes 25% of IDLs to LDLs (remaining LDLS bind to remnant receptors (via apo E) or LDL receptors (via apo B)
-can break apart phospholipids

LOCATION
-sinusoidal surfaces of liver only

REGULATION
-also activated by ApoCII

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

LO6: Describe the steps involved in the reverse transport of cholesterol (4)

A

NET TRANSFER OF CHOLESTEROL FROM TISSUES TO LIVER FOR PROCESSING FOR EXCRETION

  1. Cholesterol is removed from peripheral tissues by HDL (requires ApoA-1)
    - rate controlling step; mediated by ATP-binding cassette transporter (ABCA1)
  2. Cholesterol can then be esterified by LCAT (in plasma)
    - stimulated by Apo A-1
    - then transferred to core of HDL particle or to other lipoprotein remnants
  3. Esters transferred from HDL to lipoprotein remnants, in space created by lipoprotein lipase-catalyzed hydrolysis of triglycerides (mediated by Apo D)
  4. HDL cholesterol esters then transferred to tissues via scavenger receptor B1, which takes up esters but not HDL
    - B1 expressed on liver, adrenals, testes, ovaries, and macrophages in atherosclerotic plaques

Steps 3+4 regenerates lipid-poor HDL, which can reinitiate the cycle at Step 1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

LO7: Compare/contrast LDL receptors and remnant receptors with respect to their location and function in lipid metabolism

A

LDL RECEPTORS

  • bind ApoB-100 protein
  • on liver cells
  • assist with LDL and ILDL uptake and recycling
  • less localized/more prolific (found in peripheral tissues also)
  • synthesis regulated by [cholesterol]

REMNANT RECEPTORS

  • bind Apo E protein
  • on liver cells
  • assist with LDL and ILDL uptake and recycling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

LO8: Describe two metabolic fates of IDLs

A

-either taken up by liver, or further metabolized by hepatic lipase to LDLs (lose ApoCII and ApoE)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

LO9: Compare/contrast the properties of LDL receptors and scavenger receptors

A

LDL RECEPTORS

  • bind ApoB-100 protein
  • on liver cells
  • assist with LDL (75%) and ILDL uptake and recycling
  • less localized/more prolific (found in peripheral tissues also)
  • synthesis regulated by [cholesterol]

SCAVENGER RECEPTORS

  • removes 25% of plasma LDLs
  • located on macrophages
  • synthesis not regulated by [cholesterol]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

LO10: Describe the metabolic role of the ABCA1 protein and name the disorder that results from a defect or deficiency in this protein

A

-assists with transfer of unesterified cholesterol/phospholipids from peripheral cells to nascent HDL (rate-limiting step of reverse cholesterol transport)

TANGIER’S DISEASE

  • deficiency in HDL secondary to deficiency in ABCA1 protein
  • results in low Apo A1 levels (1-3% of normal)
  • decreased cholesterol and increased triglycerides
  • diagnosed in early childhood, as tonsils become enlarged/yellow orange as they fill with foam cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

LO11: Describe the molecular defect underlying familial hypercholesterolemia

A

TYPE II HYPERLIPOPROTEINEMIA

  • inherited defect in LDL receptor, so LDLs can’t be taken up from the blood
  • most common disease in lipid metabolism
  • carriers have increased risk of atherosclerotic plaques/disease (autosomal dominant)
  • homozygotes have very severe disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly